CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
E Osby, H Hagberg, S Kvaloy, L Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, H Holte, J Myhre, H Pertovaara, M Bjorkholm
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial'. Together they form a unique fingerprint.